Travers Smith-Led DBAY Bids £350M For Alliance Pharma

Asset manager DBAY Advisors said Friday that it and a European private equity fund have agreed to acquire British consumer healthcare company Alliance Pharma for approximately £350 million ($428 million) in...

Already a subscriber? Click here to view full article